These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1899854

  • 1. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.
    Andersson ML, Stam NJ, Klein G, Ploegh HL, Masucci MG.
    Int J Cancer; 1991 Feb 20; 47(4):544-50. PubMed ID: 1899854
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426
    [Abstract] [Full Text] [Related]

  • 5. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 01; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.
    Imreh MP, Zhang QJ, de Campos-Lima PO, Imreh S, Krausa P, Browning M, Klein G, Masucci MG.
    Int J Cancer; 1995 Jul 04; 62(1):90-6. PubMed ID: 7601573
    [Abstract] [Full Text] [Related]

  • 7. Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines.
    Masucci MG, Stam NJ, Torsteinsdottir S, Neefjes JJ, Klein G, Ploegh HL.
    Cell Immunol; 1989 May 04; 120(2):396-400. PubMed ID: 2541930
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G.
    Proc Natl Acad Sci U S A; 1987 Jul 04; 84(13):4567-71. PubMed ID: 3037521
    [Abstract] [Full Text] [Related]

  • 9. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L, Trivedi P, de Campos-Lima PO, Zhang QJ, Ragnar E, Klein G, Masucci MG.
    Mol Immunol; 1993 Apr 04; 30(5):441-50. PubMed ID: 7681932
    [Abstract] [Full Text] [Related]

  • 10. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
    Masucci MG, Klein E.
    Semin Cancer Biol; 1991 Feb 04; 2(1):63-71. PubMed ID: 1655115
    [Abstract] [Full Text] [Related]

  • 11. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
    Jilg W, Voltz R, Markert-Hahn C, Mairhofer H, Münz I, Wolf H.
    Cancer Res; 1991 Jan 01; 51(1):27-32. PubMed ID: 1899042
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H.
    Int J Cancer; 1993 Feb 20; 53(4):621-7. PubMed ID: 8382194
    [Abstract] [Full Text] [Related]

  • 13. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD, Rowe M, Rickinson AB.
    J Gen Virol; 1990 Jul 20; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [Abstract] [Full Text] [Related]

  • 14. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG.
    Int J Cancer; 1994 Apr 15; 57(2):240-4. PubMed ID: 8157362
    [Abstract] [Full Text] [Related]

  • 15. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
    Frisan T, Zhang QJ, Levitskaya J, Coram M, Kurilla MG, Masucci MG.
    Int J Cancer; 1996 Oct 09; 68(2):251-8. PubMed ID: 8900437
    [Abstract] [Full Text] [Related]

  • 16. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG.
    Cancer Surv; 1992 Oct 09; 13():53-80. PubMed ID: 1330300
    [Abstract] [Full Text] [Related]

  • 17. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC, Woisetschlaeger M, Strominger JL, Speck SH.
    Proc Natl Acad Sci U S A; 1991 Aug 01; 88(15):6550-4. PubMed ID: 1713681
    [Abstract] [Full Text] [Related]

  • 18. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H, Rowe M, Murray R, Brooks J, Rickinson A.
    Eur J Immunol; 1992 Jul 01; 22(7):1741-8. PubMed ID: 1378014
    [Abstract] [Full Text] [Related]

  • 19. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I, Kallin B, Dillner J, Falk K, Ehlin-Henriksson B, Hammarskjöld ML, Klein G.
    Int J Cancer; 1986 Nov 15; 38(5):729-37. PubMed ID: 3021635
    [Abstract] [Full Text] [Related]

  • 20. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC, Strominger JL, Speck SH.
    Proc Natl Acad Sci U S A; 1995 Nov 07; 92(23):10565-9. PubMed ID: 7479841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.